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Abstract
Cryptococcal meningoencephalitis has an overall global mortality rate of 20% in AIDS patients despite antifungals. There is a
need for additional means of precise assessment of disease severity. We thus studied the radiological brain images available
from 62 HIV-positive patients with cryptococcocal meningoencephalitis to analyse the brain lesions associated with
cryptococcosis in relationship with disease severity, and the respective diagnostic contribution of magnetic resonance (MR)
versus computed tomography (CT). In this retrospective multicenter analysis, two neuroradiologists blindly reviewed the
brain imaging. Prospectively acquired clinical and mycological data were available at baseline and during follow-up.
Baseline images were abnormal on 92% of the MR scans contrasting with 53% of the CT scans. MR/CT cryptococcosis-
related lesions included mass(es) (21%/9%), dilated perivascular spaces (46%/5%) and pseudocysts (8%/4%). The presence
compared to absence of cryptococcosis-related lesions was significantly associated with high serum (78% vs. 42%, p=0.008)
and CSF (81% vs. 50%, p=0.024) antigen titers, independently of neurological abnormalities. MR detected significantly more
cryptococcosis-related lesions than CT for 17 patients who had had both investigations (76% vs. 24%, p=0.005). In
conclusion, MR appears more effective than CT for the evaluation of AIDS-associated cerebral cryptococcosis. Furthermore,
brain imaging is an effective tool to assess the initial disease severity in this setting. Given this, we suggest that investigation
for cryptococcosis-related lesions is merited, even in the absence of neurological abnormality, if a high fungal burden is
suspected on the basis of high serum and/or CSF antigen titers.
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Introduction
Cryptococcus neoformans is an encapsulated yeast responsible for
severe opportunistic meningoencephalitis mostly in patients with
acquired immunodeficiency syndrome (AIDS) [1–3]. C. neoformans
var grubii is by far the predominant serotype in HIV-infected patients
worldwide. The main presentation is a disseminated meningoen-
cephalitis [1–3]. Retrospective radiological studies involving a
limited number of HIV-infected patients with cerebral cryptococ-
cosis have been performed in the pre-highly active antiretroviral
therapy (HAART) era [4–7]. They describe the abnormal cerebral
images during cryptococcal meningoencephalitis. The introduction
of HAART has significantly modified the radiological presentation
of other opportunistic infections [8]. Given this, it is possible that
HAART may also have had an impact on the radiological
appearances of cerebral cryptococcosis. This is a particularly
interesting theory when considering the demonstrated effect of
protease inhibitors on some opportunistic pathogens and, specifical-
ly, the impact of indinavir or tipranavir on cryptococcal virulence
[9–10]. Radiological data obtained during the post-HAART era is
therefore important, as all the data published so far consists of case
reports or small series (n#4) of HIV-infected patients [11–26].
Cryptococcal meningoencephalitis is still associated with an
overall 20% mortality rate despite appropriate antifungal therapy,
underlining the urgent need for improved management strategies.
Most HIV-infected patients with acute neurological symptoms will
undergo radiological brain evaluation. However no study has, to
date, specifically evaluated the potential utility of neuroimaging to
assess the initial severity of AIDS-associated cryptococcosis.
Furthermore, analysis of the respective contribution of cranial
computed tomography (CT) versus magnetic resonance (MR) in
detecting cryptococcal lesions is scarce, in contrast to other
opportunistic infections where the beneficial contribution of MR
has been clearly established [4,27].
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e1950The aim of the present study was thus to answer these questions
using data from a large prospective cohort of HIV-infected
patients with culture-proven cryptococcal meningoencephalitis
and for whom brain images were available at baseline and during
follow-up [3]. In addition, our results were compared with
published data on brain imaging during cryptococcosis after a
systematic review of the literature.
Results
Characteristics of the study population
Sixty two HIV-infected patients were analysed. Of these, 49
(79%) were men, with a median age of 36 years [IQR, 33–44].
Twenty-four (24/62, 39%) were receiving HAART at the time of
cryptococcosis diagnosis. Twenty-two (22/62, 36%) patients were
reported to have had previous opportunistic infection(s) including
cerebral toxoplasmosis (n=10). Two patients were diagnosed
concomitantly with cerebral toxoplasmosis and cryptococcal
meningoencephalitis. At baseline, 24 patients had been diagnosed
with AIDS for a median of 21 months [IQR, 5–43]. Median viral
load was 5.1 log ARN cop/ml [IQR, 4.4–5.5], and median CD4
+
cell count was 18/mm
3 [IQR, 7–41]. Twenty seven patients
(27/62, 44%) presented with neurological abnormality (ies) at the
time of diagnosis, and high serum and cerebrospinal fluid antigen
titers (i.e., $512) were reported in 34/58 (59%) and 35/56 (63%)
of the patients respectively. Serotype A was involved in 49/59
(83%), and serotype D in 10/59 (17%) of the cases.
Radiological findings at baseline
Description of baseline findings. The mean interval
between onset of symptoms and initial neuroimaging was 24
days (range 0–104 days). At baseline, 45 patients had single
imaging (38 CT, 7 MR), and 17 patients had dual exploration.
Baseline CT and MR were normal in 26/55 (47%) and 2/24 (8%)
of the patients, respectively (Table 1). Cryptococcosis-related
lesions found on CT were rare (13/55, 24%) and, in decreasing
order of frequency, consisted of: intracerebral mass(es) (5/55, 9%),
dilated VR spaces (3/55, 5%), pseudocysts, hydrocephalus (not
attributable to other opportunistic infections), radiological
meningitis and edema (2/55, 4% each). By contrast,
cryptococcosis-related lesions were observed by MR in 19/24
(79%) cases and consisted of dilated VR spaces (11/24, 46%,
Figure 1A), masses (5/24, 21%, Figure 1B), pseudocysts and
meningitis (including one case of meningitis with subdural
empyema) (2/24, 8% each, Figures 1C, 1D). Nodules or masses
(5–40 mm in diameter) were located in the frontal, parietal,
occipital gyri, the basal ganglia or corpus callosum. Some lesions
were enhanced after contrast medium injection, and perilesional
edema was observed in one patient with both procedures. One
patient with an enhancing mass had possible concomitant cerebral
toxoplasmosis.
HAART intake at baseline was not associated with any specific
radiological pattern (data not shown). Based on 59 CT images,
there was no difference in the percentage of abnormal lesions as a
whole, nor specifically of cryptococcosis-related lesions according
to the infecting serotype A (n=49) or D (n=10) (data not shown).
Relationship between baseline cerebral images and
initial severity or outcome. We then assessed whether any
of the radiological features were associated with initial severity or
specific outcome. High serum and CSF antigens titers at baseline
were recorded in 21/27 (78%) and 21/26 (81%) patients with
cryptococcosis-related lesions respectively, but only in 13/31
(42%) and 14/28 (50%) patients without (p=0.008 and p=0.024,
respectively). In the multivariate analysis, parameters
independently associated with cryptococcosis-related cerebral
lesions were high serum antigen titers (OR [95% CI]=4.6 [1.4–
15.1], p=0.012) and neurological abnormalities (OR [95%
CI]=2.9 [0.9–9], p=0.076). Similarly, high CSF antigen titers
Table 1. Neuroradiological analysis of 55 computed tomographies and 24 magnetic resonance images collected at baseline from
62 HIV-infected patients with culture-proven cryptococcal meningoencephalitis.
Result of brain imaging Computed tomography (n=55) Magnetic resonance (n=24)
Normal imaging 26 (47%) 2 (8%)
Cryptococcosis-related lesions 13 (24%) 19 (79%)
VR dilatation 3 11
Pseudocysts 2 2
Intracerebral mass(es) [unique/multiple] 5 [3/2] 5 [3/2]
Hydrocephalus 2 -
Radiological meningitis 2
a 2
Other lesions
b 20 (36%) 11 (45.8%)
HIV-encephalopathy 5 6
Cerebral atrophy 6 4
Progressive multifocal leukoencephalopathy 1 1
Diffuse cerebral edema 2 -
Superior sagittal sinus thrombosis 1 -
Ischemic lacuna 3 2
Basal ganglia vasculitis - 1
Aspecific hypodensities 4 -
Aspecific hyperintense T2 signals - 2
aWith evidence of subdural collection.
bSome patients had more than one lesion.
doi:10.1371/journal.pone.0001950.t001
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of neurological abnormalities (adjusted-OR [95% CI]=4.3 [1.2–
15.0], p=0.02). A higher proportion of dilated VR spaces was
found in patients with high serum antigen titers compared to
patients without (11/34 (32%) vs. 2/24 (8%), p=0.053). No
association was found between the existence of cryptococcosis-
related lesions and other markers of initial severity, i.e. low CSF
white-cell count, elevated CSF protein concentration or
hyponatremia at baseline (data not shown).
No statistically significant association was found between
cryptococcosis-related lesions as a whole or any specific lesions
seen at baseline and the occurrence of mycological failure at the
week 2 and month 3 workups or further development of IRIS.
Indeed, the 4 patients with IRIS had various baseline CT lesions
(intracerebral masses, aspecific caudate nucleus hypodensities,
cortico-subcortical atrophy and no lesion, n=1 each).
Comparison of CT and MR results for patients with dual
exploration. Seventeen patients underwent dual exploration
because of local protocols, or slightly delayed availability of MRI
(Table 2). Clinical presentation for these patients was similar to
those reported for the group of patients who had undergone a
single radiological investigation, with the same proportion of
reported neurological abnormalities (9/17 (53%) and 18/45 (40%)
respectively, p.0.5). However they appeared to be more severely
infected than the rest of the cohort, with a significantly higher
frequency of elevated serum antigen titers (14/17 (82%) vs. 20/41
(49%) respectively, p=0.022) and CSF antigen titers (14/16 (88%)
vs. 21/38 (55%), respectively, p=0.03). For these 17 patients,
cryptococcosis-related lesions were significantly more frequently
observed by MR than by CT (13/17(76%) vs. 4/17 (24%),
p=0.005), with more frequent visualization of abnormal VR
spaces by MR than by CT (8/17 (47%) versus 1/17 (6%),
p=0.017). The proportion of other lesions, however, did not differ
according to the investigation performed.
Radiological findings during the course of cryptococcal
meningoencephalitis
Clinical and mycological data were available for 57 patients
during follow-up. Of these, 12 (21.5%) died before month 3, with
death related to cryptococcosis for 7/12 (58%). Four patients were
subsequently diagnosed with IRIS within a median of 11 months
(range, 3–38 months) and neurological sequelae were reported in 6
of the 45 survivors (14%).
Of the 57 patients, 24 patients had repeated radiological
procedures, allowing comparison of consecutive images over 3
months. At baseline, these 24 patients were more severely infected
with more frequently higher serum antigen titers than the other
patients (18/23 (78%) vs. 46%, p,0.001). They also had more
subsequent neurological sequelae (5/16 (31%) vs. 1/28 (4%),
p=0.018).
Figure 1. Examples of abnormal radiological findings. A. Magnetic Resonance axial T2-weighted image, displaying bilateral dilated Virchow-
Robin spaces (arrow) in the basal ganglia. B. Magnetic Resonance axial T2-weighted image displaying a hyperintense right occipital mass (arrow head)
and bilateral dilated Virchow-Robin spaces (arrow). C. Magnetic Resonance axial T1-weighted image with contrast infusion displaying frontal subdural
collection (arrow). D. Magnetic Resonance axial T1-weighted image with contrast infusion displaying a basal meningeal enhancement (arrow).
doi:10.1371/journal.pone.0001950.g001
Table 2. Initial computed tomography and magnetic resonance findings among the 17 patients with dual explorations during
culture-proven cryptococcal meningoencephalitis.
Imaging findings, % (n) Computed tomography Magnetic resonance p-value
Normal 47.1% (8) 5.9% (1) 0.085
Cryptococcosis-related lesions 23.5% (4) 76.4% (13) 0.005
VR dilatation 5.9% (1) 47.1% (8) 0.017
Pseudocysts 0 11.8% (2) 0.485
Intracerebral nodule(s) or mass(es) 17.6% (3) 17.6% (3) 1
Hydrocephalus 0% (0) 0% (0) -
Radiological meningitis 0% (0) 5.9% (1) 1
doi:10.1371/journal.pone.0001950.t002
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(exacerbation, stability or improvement of cryptococcosis-related
or unrelated lesions) and outcome at month 3 including
occurrence of IRIS.
Review of reported series in the HIV-infected population
All published series were performed during the pre-HAART era
and were retrospective in design (Table 3) [4–6,26,28–34]. They
involved less than 20 patients in all but 4 studies [4,7,30–31]. Four
of them involved the use of autopsy findings in order to ascertain
any radio-pathological correlations. [5,7,26,35]. Taking into
account this semantic diversity, the main lesions visualized by
CT in these pre-HAART series were masses (6 to 37.5%, [4,5]),
hydrocephalus (8 to 20%, [30,34]) and pseudocysts (6 to 40%,
[26,31]), while the main lesions observed by MR were dilated VR
spaces (56 to 100%, [5–6]), masses (11 to 60%, [4,6]) and
radiological meningitis (17 to 78%, [6,29]), best visualised after
double dose contrast medium injection [6].
Radio-pathological comparisons underlined the overall low
performance of both MR and CT to detect fungal meningitis which
was a constant at autopsy [5,26,36]. Several studies pointed out the
lack of radiological hydrocephalus in cases of high opening CSF
pressure [21,29,37–40]. Radiological cerebral atrophy was frequent-
lynoted($30% [4,31]). CTimages were reported as normal inmore
than 40% of cases in the 10/12 series and MRI reported as normal
in around 10% of cases in the 4 MR pre-HAART series.
Discussion
We analysed the radiological features of cerebral cryptococcosis
in a large prospective cohort of HIV-infected patients in the
HAART era and compared brain images with parameters
assessing disease severity [3].
The pattern of cryptococcosis-related lesions recorded by CT
consisted, here, of predominantly dilated VR spaces, masses and
meningitis and on MR images, of mass(es) and pseudocysts with,
rarely, radiological meningitis and hydrocephalus, as reported in
the pre-HAART era in the available series (Table 3) [4–6,26,28–
34]. Radiological cerebral atrophy however appeared less
frequently here than previously reported (#13% here vs. $30%
[4,31]), probably because of the diminished incidence of HIV-
associated dementia and because cryptococcosis is more often
revelatory of AIDS than in the pre-HAART era [41]. Thus, it
would appear that the advent of HAART has had no influence on
the development of cryptococcal-related lesions (including inflam-
matory lesions) despite its demonstrated effect on fungal virulence
and on the local production of IL-8 [9–10,42]. Strikingly, and in
agreement with pre-HAART studies, normal brain imaging (47%
by CT and 8% by MR) did not rule out cryptococcal
meningoencephalitis. Finally, as reported elsewhere [43], other
opportunistic infections can be concomitantly diagnosed (as was
the case in 2 of our patients).
The value of brain imaging for assessing AIDS-associated
cryptococcosis’ initial severity was analyzed. We have previously
shown that abnormal brain images were associated with a higher
risk of death within three months after the diagnosis [3]. Here, a
significant association was found between the existence of
cryptococcosis-related radiological brain lesions at baseline and
high serum or CSF antigen titers, two major prognostic markers
[3]. This association was found even in patients with normal
neurological examinations. The Infectious Diseases Society of
America guidelines for the management of cryptococcosis,
Table 3. Published series (1982–2007) of more than 5 HIV-infected adult cases on radiological presentation of cerebral
cryptococcosis.
References Year Country HIV-status
No. of patients
wC T
a or MR
b Main findings, n (%)
Normal
Dilated VR
spaces Pseudocysts Mass(es)
Hydroce
phalus
Radiological
meningitis
Other
lesions
[28] 1985 USA HIV+ 10 CT 8 (80%) - - - - - 2 (20%)
[32] 1986 USA HIV+ 13 CT 9 (69%) - - 2 (15%) 1 (8%) - 1 (8%)
[31] 1990 USA 28 HIV+ 35 CT 15 (29%) - 2 (6%) 2 (6%) 3 (9%) - 13 (37%)
7I DH I V 2
[4] 1990 USA HIV+ 29 CT 9 (31%) - - 5 (17%) - - 15 (52%)
[4] 1990 USA HIV+ 10 MR* 0 6 (60%) - 6 (60%) - - -
[5] 1992 USA HIV+ 8 CT 1 (12.5%) - - 3 (37.5%) - - 3 (37.5%)
[5] 1992 USA HIV+ 5 MR 0 5 (100%) - 1 (20%) - 1 (20%) 2 (40%)
[6] 1993 Italy HIV+ 9 MR 0 5 (56%) 1 (11%) 1 (11%) - 7 (78%) -
[29] 1994 Germany HIV+ 8 CT 5 (62.5%) - - - - - 3 (37.5%)
[29] 1994 Germany HIV+ 6 MR 3 (50%) - - 1 (17%) - 1 (17%) 1 (17%)
[30] 1996 France HIV+ 48 CT 33 (69%) - - 4 (8%) 4 (8%) 2 (4%) 5 (10%)
[33] 1997 Spain HIV+ 17 CT 8 (41%) - - 2 (12%) - - 8 (47%)
[34] 1997 South
Africa
HIV+ 15 CT 12 (80%) - - - - - 3 (20%)
[26] 1997 USA HIV+ 10 CT 4 (40%) - 4 (40%) - 2 (20%) - -
Our study 2007 France HIV+ 55 CT 26 (47%) 3 (5%) 2 (4%) 5 (9%) 2 (4%) 2 (4%) 20 (36%)
Our study 2007 France HIV+ 24 MR 2 (8%) 11 (46%) 2 (8%) 5 (21%) - 2 (8%) 11 (46%)
aCT: computed tomography.
bMR: magnetic resonance image.
doi:10.1371/journal.pone.0001950.t003
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lumbar puncture in cases of neurological abnormalities [44]. Our
study suggests that: (i) neuroimaging, especially MR, should be
considered as a valuable tool to assess cryptococcosis’ initial
severity in HIV-infected patients, along with other prognostic
markers and that (ii) cryptococcosis-related lesions may deserve
appraisal even in the absence of neurological abnormalities if a
high fungal burden is suspected on the basis of high serum and/or
CSF antigen titers.
The question of which investigation should be performed is
often answered by which is available faster. MR has clearly been
demonstrated to be more accurate than CT for the investigation of
other cerebral lesions [29,45–46]. Two preliminary comparisons
of CT and MR in,respectively, 10 and 8 immunocompetent/
compromised patients with cryptococcal meningoencephalitis
suggested a higher efficiency of MR over CT for the visualization
of VR spaces [4,47] possibly because of the limited inflammation
[5,26]. Here, cryptococcosis-related lesions were significantly more
frequently observed on MR than on CT images for 62 HIV-
infected patients including 17 for whom both investigations were
performed. Of note, the VR spaces which appear as the main
anatomical site involved, radiologically, during cerebral crypto-
coccosis are also the site of brain invasion associated with
fungemia in a relevant murine model of disseminated cryptococ-
cosis [48–50]. Considering its high performance, cerebral MR
imaging of infected mice should be a powerful tool for further
dissection of cerebral cryptococcosis pathophysiology.
The current guidelines do not comment on the need to repeat
radiological investigations [44]. Twenty four patients in our cohort
had multiple neuroimaging. They were more likely to have more
severe disease and a poorer outcome, an observation consistent
with daily practice. Our data from this large subgroup of patients
does not support repeated neuromaging in clinically and
mycologically stable patients. However, neurologically unstable
patients would benefit from further radiological evaluations,
keeping in mind the possibility of new opportunistic infections
and IRIS [51–53].
In conclusion, our study suggests that brain imaging, especially
by MR, is an additional effective tool in the assessment of initial
disease severity in AIDS-associated cryptococcosis. The absence of
neurological abnormality should not preclude neuroimaging
especially in cases of suspected high fungal burden on the basis
of high antigen titers.
Materials and Methods
Study population
Sixty two patients with culture-proven cryptococcal meningo-
encephalitis and available brain imaging were analysed from 21
hospitals in Paris area. These patients were enrolled onto the
nationwide multicentric prospective CryptoA/D study [3].
Written informed consent had been obtained in accordance with
the French Ethical Committee Recommendations.
Clinical, biological and mycological data were available at
baseline for all patients and at 2 weeks and 3 months of antifungal
therapy for 57 patients. Initial severity and prognosis was
evaluated, as already described [3]. Briefly, initial severity was
assessed according to the existence of neurological abnormalities
and high ($512) serum or CSF cryptococcal antigen titers. Low
CSF white-cell count (,20/ml), elevated CSF protein concentra-
tion or hyponatremia were also recorded. Mycological failure after
2 weeks of antifungal therapy corresponded to the persistence of
viable yeasts in at least one body system. Treatment failure was
defined for the patients followed up to 3 months after the diagnosis
of cryptococcosis and consisted of death, persistence of viable
yeasts in culture or neurological sequelae. Immune reconstitution
inflammatory syndrome (IRIS) was defined according to the
literature [52].
Radiological investigations
Neuroimaging was performed according to local practices. All
brain CT and MR images available from baseline to 3 months
after the diagnosis were collected and blindly analyzed by
neuroradiologists experienced in the field of AIDS-associated
opportunistic central nervous system infections. Brain lesions were
recorded following a pre-established checklist.
The following items were analysed according to the available
pre-HAART literature on brain cryptococcal lesions: dilated
Virchow-Robin (VR) spaces [4–7,26,54], pseudocysts (also called
‘‘gelatinous pseudocysts’’ [6] and ‘‘soap bubbles’’ [35], corre-
sponding to fungal proliferation in VR spaces invading the
surrounding parenchyma [6] or to confluent VR spaces [26]);
intracerebral nodules or masses (also called nodular lesions [4],
granulomas [55], cryptococcomas [5–7,31] or brain fungal
abscesses [31–32,56–57]); hydrocephalus and radiological menin-
gitis or its complications [58]. Cryptococcosis-related lesions were,
here, defined by the presence of at least one of the following
images: dilated VR spaces, pseudocysts, intracerebral masses and
hydrocephalus. Images of progressive multifocal leukoencepha-
lopathy, cerebral atrophy, or features compatible with HIV
encephalopathy were also noted, as well as any other abnormal-
ities. Lesions were considered as sequelae if they had the
appearance of ischemic infarcts, were calcified without peripheral
edema or mass effect and did not enhance with intravenous
contrast enhancement, and were thus excluded from the analysis.
Baseline MR and CT images were obtained within 7 days
before and up to 14 days after the mycological diagnosis of
cryptococcal meningoencephalitis. A minimum of 2 weeks was
required between two consecutive procedures to evaluate potential
changes. Dual exploration (CT and MR for the same patient) was
defined if both investigations were performed within a period of
two consecutive weeks. Radiological evolution was evaluated on
images obtained by the same procedure (CT or MR) and classified
as an exacerbation (i.e., increase in size and/or number of lesions
or apparition of any new lesions), a complete or partial response
(i.e., disappearance or decrease of more than 50% in the number
and/or size of lesions), or otherwise as stable.
Review of reported series in the HIV-infected population
We reviewed and analyzed the literature through a Medline
search (up to October 2007). All series including more than 5
HIV-infected cases published in English or French were selected
using combinations of brain/cerebral, magnetic resonance imag-
ing/computed tomography, X-Ray, and cryptococcosis/crypto-
coccal, meningitis/meningoencephalitis as key words. Cases due to
C. gattii were excluded because of the reported distinct pattern in
terms of geographical distribution, underlying diseases and types of
tissue lesions [59].
Statistical analysis
The prevalence of every radiological feature at baseline was
determined for all the CT and MR images collected. Then, the
association between the presence of cryptococcosis-related lesions
at baseline and initial severity parameters with the subsequent
occurrence of mycological failure, death, neurological sequelae or
IRIS was studied using results obtained with either CT or MR
(and considering only MR results in cases of dual exploration).
Cryptococcosis: Brain Imaging
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statistical package (Stata Corporation, College Station, Texas,
USA). Continuous variables were compared using the non-
parametric Mann-Whitney rank sum test. The chi-square or
Fisher’s exact test was used to assess significant relationships
between discrete variables. The Mac Nemar exact test was used to
compare the proportion of positive findings with CT and MR in
cases of dual exploration. Two-sided p values less than 0.05 were
regarded as significant. Multivariate analysis with logistic regression
was performed to determine factors associated with cryptococcosis-
relatedlesions. Odds ratios (OR) and their 95%confidenceintervals
[95%CI] were determined by means of logistic regression analysis.
All variables that were clinically relevant with p value ,0.25 in
univariate analysis were entered simultaneously into the initial
model. A backward stepwise procedure was used to remove
variables until all variables retained in the final model had p values
,0.05. Interactions were explored by means of interaction terms
added to the logistic regression model.
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